Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Induced Resistance to Bortezomib in Preclinical Model of Waldenstrom Macroglobulinemia Is Associated with Bcl-2 Upregulation.

Kasyapa Chitta, Ph.D., Jean-Gabriel Coignet, Sakina Sojar, Pushpankur Ghoshal, PhD, Kiersten M. Miles, Leighton Stein, Morton Coleman, MD, Richard R. Furman, MD, Craig Hofmeister, MD, Suzanne Hayman, MD, Kelvin P. Lee, MD, Asher A. Chanan-Khan, MD

Blood (2009) 114 (22): 4919.

https://doi.org/10.1182/blood.V114.22.4919.4919

Published: 2009

Journal Articles

Weight Adjusted Low-Dose Warfarin Decreases the Incidence of Thalidomide (T) Associated Venous Thromboembolism (VTE) in Patients (pts) with Multiple Myeloma (MM) and Waldenstroms Macroglobulinemia (WM).

Kena C. Miller, NP, Rami Manochakian, Swaminathan Padmanabhan, MD, Jean-Gabriel Coignet, Laurie Musial, Dawn DePaolo, Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 4101.

https://doi.org/10.1182/blood.V108.11.4101.4101

Published: 2006

Journal Articles

Incidence, Clinical Presentation and Outcome of Secondary Multiple Extramedullary Plasmacytomas: Experience at Roswell Park Cancer Institute.

Rami Manochakian, MD, Kena C. Miller, Jean-Gabriel Coignet, Swami Padmanabhan, MD, Laurie Musial, Dawn DePaolo, Asher Alban Chanan-Khan

Blood (2006) 108 (11): 5057.

https://doi.org/10.1182/blood.V108.11.5057.5057

Published: 2006

Journal Articles

Co-Expression of CD38 with Zap-70 Is Predictive of Treatment Intervention in Patients (pts) with Early Stage Chronic Lymphocytic Leukemia (CLL).

Jean-Gabriel Coignet, Swaminathan Padmanabhan, MD, Rami Manochakian, MD, Kena C. Miller, NP, Paul Wallace, Ph.D., AnneMarie Block, Ph.D., Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 4945.

https://doi.org/10.1182/blood.V108.11.4945.4945

Published: 2006

Journal Articles

Osteonecrosis of the Jaw (ONJ) in Patients with Multiple Myeloma, Receiving Bisphosphonate Therapy, Is Independent of Renal Function: Single Institute Experience of an Emerging Clinical Problem.

Rami Manochakian, Jean-Gabriel Coignet, Swaminathan Padmanabhan, Maureen Sullivan, Kena C. Miller, Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 5129.

https://doi.org/10.1182/blood.V108.11.5129.5129

Published: 2006

Journal Articles

Low-Dose Prednisone Decreases the Severity but Not the Frequency of Lenalidomide Associated Tumor Flare Feaction (TFR) in Chronic Lymphocytic Leukemia (CLL) Patients.

Laurie Musial, Kena C. Miller, Amy Tonelli, Rami Manochakian, Swaminathan Padmanabhan, David Lawrence, Dawn DePaolo, Jean-Gabriel Coignet, Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 4987.

https://doi.org/10.1182/blood.V108.11.4987.4987

Published: 2006

NARROW

Induced Resistance to Bortezomib in Preclinical Model of Waldenstrom Macroglobulinemia Is Associated with Bcl-2 Upregulation.

Weight Adjusted Low-Dose Warfarin Decreases the Incidence of Thalidomide (T) Associated Venous Thromboembolism (VTE) in Patients (pts) with Multiple Myeloma (MM) and Waldenstroms Macroglobulinemia (WM).

Incidence, Clinical Presentation and Outcome of Secondary Multiple Extramedullary Plasmacytomas: Experience at Roswell Park Cancer Institute.

Co-Expression of CD38 with Zap-70 Is Predictive of Treatment Intervention in Patients (pts) with Early Stage Chronic Lymphocytic Leukemia (CLL).

Osteonecrosis of the Jaw (ONJ) in Patients with Multiple Myeloma, Receiving Bisphosphonate Therapy, Is Independent of Renal Function: Single Institute Experience of an Emerging Clinical Problem.

Low-Dose Prednisone Decreases the Severity but Not the Frequency of Lenalidomide Associated Tumor Flare Feaction (TFR) in Chronic Lymphocytic Leukemia (CLL) Patients.

Email alerts

ASH Publications

American Society of Hematology

Induced Resistance to Bortezomib in Preclinical Model of Waldenstrom Macroglobulinemia Is Associated with Bcl-2 Upregulation.

Weight Adjusted Low-Dose Warfarin Decreases the Incidence of Thalidomide (T) Associated Venous Thromboembolism (VTE) in Patients (pts) with Multiple Myeloma (MM) and Waldenstroms Macroglobulinemia (WM).

Incidence, Clinical Presentation and Outcome of Secondary Multiple Extramedullary Plasmacytomas: Experience at Roswell Park Cancer Institute.

Co-Expression of CD38 with Zap-70 Is Predictive of Treatment Intervention in Patients (pts) with Early Stage Chronic Lymphocytic Leukemia (CLL).

Osteonecrosis of the Jaw (ONJ) in Patients with Multiple Myeloma, Receiving Bisphosphonate Therapy, Is Independent of Renal Function: Single Institute Experience of an Emerging Clinical Problem.

Low-Dose Prednisone Decreases the Severity but Not the Frequency of Lenalidomide Associated Tumor Flare Feaction (TFR) in Chronic Lymphocytic Leukemia (CLL) Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only